Argent BioPharma Revenue

Argent BioPharma had revenue of 4.28K AUD in the half year ending December 31, 2024, a decrease of -99.84%. This brings the company's revenue in the last twelve months to 295.83K, down -77.66% year-over-year. In the fiscal year ending June 30, 2024, Argent BioPharma had annual revenue of 891.08K, down -73.70%.

Revenue (ttm)

295.83K AUD

Revenue Growth

-77.66%

P/S Ratio

26.93

Revenue / Employee

n/a

Employees

n/a

Market Cap

4.93M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	891.08K	-2.50M	-73.70%
Jun 30, 2023	3.39M	-1.34M	-28.41%
Jun 30, 2022	4.73M	1.74M	57.94%
Jun 30, 2021	3.00M	916.88K	44.10%
Jun 30, 2020	2.08M	1.42M	216.83%
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro
Jun 30, 2016	Pro	Pro	Pro
Jun 30, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.76B
Veradigm	588.02M
Tian'an Technology Group	1.78M
Glass House Brands	200.90M
Elite Pharmaceuticals	70.00M
Northwest Biotherapeutics	1.38M
BioStem Technologies	301.83M
American Oncology Network	1.76B

Revenue Rankings

Argent BioPharma News

6 weeks ago - Argent BioPharma Expands Pipeline with Promising Drug CimetrA® - PRNewsWire
2 months ago - Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management - PRNewsWire
4 months ago - Argent BioPharma Ltd. Raised US$4,500,000 - PRNewsWire
4 months ago - Argent BioPharma Ltd. Placing to Raise US$4,500,000 - PRNewsWire

More News